Displaying drugs 1926 - 1950 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Selumetinib | 457.68 C17H15BrClFN4O3 |  | A MEK 1/2 inhibitor used in pediatric patients to treat neurofibromatosis type 1 (NF1) accompanied by symptomatic, inoperable plexiform neurofibromas (PN). | Mitogen-activated protein kinase (MEK) inhibitors |
| Binimetinib | 441.233 C17H15BrF2N4O3 |  | A medication used to treat metastatic melanoma with specific mutations. | Mitogen-activated protein kinase (MEK) inhibitors / Protein Kinase Inhibitors |
| Bifonazole | 310.3917 C22H18N2 |  | An azole antifungal drug used to treat fungal skin infections, such as dermatomycosis. | Imidazole and Triazole Derivatives |
| Amrinone | 187.198 C10H9N3O |  | A positive inotropic agent and phosphodiesterase inhibitor used in the management of treatment of congestive heart failure. | Phosphodiesterase Inhibitors |
| Lisdexamfetamine | 263.3785 C15H25N3O |  | A central nervous system (CNS) stimulant used to treat attention deficit hyperactivity disorder (ADHD) and moderate to severe eating disorders. | Centrally Acting Sympathomimetics |
| Apremilast | 460.5 C22H24N2O7S |  | A non-steroidal medication used for the treatment of inflammatory conditions such as psoriasis and psoriatic arthritis. | Selective Immunosuppressants |
| Ceforanide | 519.554 C20H21N7O6S2 |  | For the treatment of infections caused by susceptible organisms. | Anti-Bacterial Agents / Second-Generation Cephalosporins |
| Tasimelteon | 245.322 C15H19NO2 |  | A melatonin receptor agonist used to treat Non- 24-Hour Sleep-Wake Disorder. | Melatonin Receptor Agonists / Receptors, Melatonin, agonists |
| Adenosine phosphate | 347.2212 C10H14N5O7P |  | For nutritional supplementation, also for treating dietary shortage or imbalance | Adenine Nucleotides / Purine Nucleotides / Ribonucleotides |
| Meticillin | 380.415 C17H20N2O6S |  | Used to treat infections caused by susceptible Gram-positive bacteria, particularly beta-lactamase-producing organisms such as Staphylococcus aureus that would otherwise be resistant to most penicillins. | Beta-Lactamase Resistant Penicillins |
| Benzylpenicillin | 334.39 C16H18N2O4S |  | A penicillin used for the treatment of infections caused by gram-positive cocci, in particular streptococcal infections. This form of penicillin is typically used in intravenous or long-acting injectable formulations due to poor oral absorption. | Beta-Lactamase Sensitive Penicillins |
| Sulthiame | 290.359 C10H14N2O4S2 |  | A carbonic anhydrase inhibitor used primarily in benign focal epilepsies of childhood that may be useful as an adjunct therapy in a variety of other refractory epilepsies. | Anticonvulsants |
| Mefenamic acid | 241.2851 C15H15NO2 |  | An NSAID used to treat mild to moderate pain for no more than a week, and primary dysmenorrhea. | Fenamates |
| Cloxacillin | 435.881 C19H18ClN3O5S |  | An antibiotic agent used for the treatment of beta-hemolytic streptococcal and pneumococcal infections as well as staphylococcal infections. | Beta-Lactamase Resistant Penicillins |
| Methylene blue | 319.85 C16H18ClN3S |  | An oxidation-reduction agent used for the treatment of pediatric and adult patients with acquired methemoglobinemia. | Tests for Gastric Secretion |
| Aminohippuric acid | 194.1873 C9H10N2O3 |  | A hippuric acid derivative injection utilized in the measurement of effective renal plasma flow (ERPF) and functional capacity of the renal excretory system. | Tests for Renal Function and Ureteral Injuries |
| Teicoplanin | 1879.67 C88H97Cl2N9O33 |  | A glycopeptide antibiotic with a similar mechanism of action and spectrum of activity to vancomycin used to treat various infections caused by gram-positive bacteria. | Glycopeptide Antibacterials |
| Brilliant blue G | 854.02 C47H48N3NaO7S2 |  | A disclosing agent used in ophthalmological surgery to stain the internal limiting membrane (ILM). | Indicators and Reagents |
| Glycerol phenylbutyrate | 530.6512 C33H38O6 |  | A nitrogen-binding agent used to manage patients with urea cycle disorders who cannot be sufficiently managed amino acid supplementation and/or dietary restrictions. | Various Alimentary Tract and Metabolism Products |
| Cefonicid | 542.566 C18H18N6O8S3 |  | For the treatment of bacterial infections caused by susceptible microorganisms. | Anti-Bacterial Agents / Second-Generation Cephalosporins |
| Sulconazole | 397.74 C18H15Cl3N2S |  | A topical antifungal agent used for the treatment of tinea cruris, tinea corporis, and tinea versicolor caused by susceptible fungal strains. | Imidazole and Triazole Derivatives |
| DL-dimyristoylphosphatidylglycerol | 666.874 C34H67O10P |  | DL-dimyristoylphosphatidylglycerol is not an considered an active pharmacological ingredient in pharmaceutical preparations and so has no official indications. | Glycerophosphates / Glycerophospholipids / Lipids / Membrane Lipids / Phosphatidic Acids / Phospholipids |
| Rifapentine | 877.0307 C47H64N4O12 |  | An antibiotic agent used in the treatment of pulmonary tuberculosis. | Anti-Bacterial Agents |
| Acetylcysteine | 163.195 C5H9NO3S |  | A medication that can be used as a mucolytic in patients with certain lung conditions and as an antidote for acetaminophen overdose. | Antidote for Acetaminophen Overdose / Antidotes / Cysteine / Expectorants / Free Radical Scavengers |
| Lorcaserin | 195.69 C11H14ClN |  | A serotonin 2C receptor agonist used in conjunction with physical activity and calorie restriction for weight loss in obese patients with a body mass index (BMI) of 30 and above, and in overweight patients with weight-related comorbidities. | Centrally Acting Antiobesity Products |
Displaying drugs 1926 - 1950 of 2785 in total